Product Information
MICROGESTIN 21 1-20 TABLET is a generic product labeled by Mayne Pharma, priced at $0.1703 per EA under NDC 51862086801. Its NADAC has been published 211 times since Oct 20, 2021.
FDA first approved this application on Dec 4, 2013. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Manufacturer
Mayne PharmaNDC
51862086801
Classification
Generic
Dosage Form
KIT
Effective Date
10/22/2025
Approval Type
Generic (ANDA)
FDA Application
ANDA202995FDA Approved
12/4/2013
TE Code
AB
On Market Since
10/12/2020
Price Statistics
The NADAC for MICROGESTIN 21 1-20 TABLET has been published 211 times since Oct 20, 2021, and over the history we have for it it has declined 47.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1703 per EA |
|---|---|
| All-time high | $0.3286 (Dec 15, 2021) |
| All-time low | $0.1619 (Nov 20, 2024) |
| 52-week high | $0.1721 |
| 52-week low | $0.1703 |
| Median price | $0.2395 |
| Average price | $0.2354 |
| Largest weekly change | +34.5% (Aug 21, 2024) |
| Weeks tracked | 211 |
| Tracking since | Oct 20, 2021 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
-1.1%
3Y
-25.0%
5Y
N/A
All
-47.7%
Last surveyed Oct 29, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Mayne Pharma manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Norethindrone Acetate/Ethinyl Estradiol market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MICROGESTIN 21 1-20 TABLET?
The current National Average Drug Acquisition Cost (NADAC) for MICROGESTIN 21 1-20 TABLET, manufactured by Mayne Pharma, is $0.1703 per EA (NDC 51862086801), effective Oct 29, 2025.
How has the price of MICROGESTIN 21 1-20 TABLET changed over time?
Over the history we have for it, the NADAC for MICROGESTIN 21 1-20 TABLET has declined 47.7%. It has been tracked across 211 weekly CMS publications since Oct 20, 2021.
What are the highest and lowest recorded NADAC prices for MICROGESTIN 21 1-20 TABLET?
Since Oct 20, 2021, the NADAC for MICROGESTIN 21 1-20 TABLET has ranged from a low of $0.1619 (Nov 20, 2024) to a high of $0.3286 (Dec 15, 2021), with a median of $0.2395 per EA.
Are there cheaper alternatives to MICROGESTIN 21 1-20 TABLET?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as MICROGESTIN 21 1-20 TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures MICROGESTIN 21 1-20 TABLET?
MICROGESTIN 21 1-20 TABLET (NDC 51862086801) is labeled by Mayne Pharma, and CMS classifies it as a generic product.